Literature DB >> 20309382

Intracranial neurostimulation for pain control: a review.

Robert Levy1, Timothy R Deer, Jaimie Henderson.   

Abstract

Intracranial neurostimulation for pain relief is most frequently delivered by stimulating the motor cortex, the sensory thalamus, or the periaqueductal and periventricular gray matter. The stimulation of these sites through MCS (motor cortex stimulation) and DBS (deep brain stimulation) has proven effective for treating a number of neuropathic and nociceptive pain states that are not responsive or amenable to other therapies or types of neurostimulation. Prospective randomized clinical trials to confirm the efficacy of these intracranial therapies have not been published. Intracranial neurostimulation is somewhat different than other forms of neurostimulation in that its current primary application is for the treatment of medically intractable movement disorders. However, the increasing use of intracranial neurostimulation for the treatment of chronic pain, especially for pain not responsive to other neuromodulation techniques, reflects the efficacy and relative safety of these intracranial procedures. First employed in 1954, intracranial neurostimulation represents one of the earliest uses of neurostimulation to treat chronic pain that is refractory to medical therapy. Currently, 2 kinds of intracranial neurostimulation are commonly used to control pain: motor cortex stimulation and deep brain stimulation. MCS has shown particular promise in the treatment of trigeminal neuropathic pain and central pain syndromes such as thalamic pain syndrome. DBS may be employed for a number of nociceptive and neuropathic pain states, including cluster headaches, chronic low back pain, failed back surgery syndrome, peripheral neuropathic pain, facial deafferentation pain, and pain that is secondary to brachial plexus avulsion. The unique lack of stimulation-induced perceptual experience with MCS makes MCS uniquely suited for blinded studies of its effectiveness. This article will review the scientific rationale, indications, surgical techniques, and outcomes of intracranial neuromodulation procedures for the treatment of chronic pain.

Entities:  

Mesh:

Year:  2010        PMID: 20309382

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  34 in total

Review 1.  Invasive brain stimulation for the treatment of neuropathic pain.

Authors:  Jean-Paul Nguyen; Julien Nizard; Yves Keravel; Jean-Pascal Lefaucheur
Journal:  Nat Rev Neurol       Date:  2011-09-20       Impact factor: 42.937

2.  Temporal patterns of deep brain stimulation generated with a true random number generator and the logistic equation: effects on CNS arousal in mice.

Authors:  A W Quinkert; D W Pfaff
Journal:  Behav Brain Res       Date:  2012-01-21       Impact factor: 3.332

Review 3.  Deep Brain Stimulation for Chronic Pain.

Authors:  Steven M Falowski
Journal:  Curr Pain Headache Rep       Date:  2015-07

Review 4.  Inflammatory mediators of opioid tolerance: Implications for dependency and addiction.

Authors:  Lori N Eidson; Anne Z Murphy
Journal:  Peptides       Date:  2019-03-16       Impact factor: 3.750

Review 5.  Deep brain stimulation.

Authors:  X L Chen; Y Y Xiong; G L Xu; X F Liu
Journal:  Interv Neurol       Date:  2013-09

Review 6.  Neuropathic pain and deep brain stimulation.

Authors:  Erlick A C Pereira; Tipu Z Aziz
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 7.  Modulating the pain network--neurostimulation for central poststroke pain.

Authors:  Koichi Hosomi; Ben Seymour; Youichi Saitoh
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

Review 8.  Visualizing the complex brain dynamics of chronic pain.

Authors:  Carl Saab
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-10       Impact factor: 4.147

9.  Reciprocal interactions between the human thalamus and periaqueductal gray may be important for pain perception.

Authors:  Dali Wu; Shouyan Wang; John F Stein; Tipu Z Aziz; Alexander L Green
Journal:  Exp Brain Res       Date:  2013-11-12       Impact factor: 1.972

10.  Neuromodulation Management of Chronic Neuropathic Pain in The Central Nervous system.

Authors:  Kai Yu; Xiaodan Niu; Bin He
Journal:  Adv Funct Mater       Date:  2020-06-10       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.